Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antanas Gulbinas

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Biochemical Pharmacology|March 16, 2025
Loss of aryl hydrocarbon receptor reduces pancreatic tumor growth by increasing immune cell infiltrationVinicius Kannen, Ninni E Olafsen, Siddhartha Das, et al.
Frontiers in Immunology|January 27, 2025
Loss of <i>Parp7</i> increases type I interferon signalling and reduces pancreatic tumour growth by enhancing immune cell infiltrationVinicius Kannen, Marit Rasmussen, Siddhartha Das, et al.
Scandinavian Journal of Gastroenterology|February 14, 2026
A decade of collaborative research: insights from the Scandinavian Baltic Pancreatic Club database on chronic pancreatitisMiroslav Vujasinovic, Mikael Parhiala, Søren S Olesen, et al.
The American Journal of Gastroenterology|February 12, 2019
Chronic Pancreatitis Is Characterized by Distinct Complication Clusters That Associate With Etiological Risk FactorsSøren S Olesen, Camilla Nøjgaard, Jakob L Poulsen, et al.
Scandinavian Journal of Gastroenterology|May 5, 2017
The Scandinavian baltic pancreatic club (SBPC) database: design, rationale and characterisation of the study cohortSøren S Olesen, Jakob L Poulsen, Asbjørn M Drewes, et al.
United European Gastroenterology Journal|February 14, 2026
International Multidisciplinary Consensus Report on Definitions, Diagnostic Criteria, and Management of Fatty Pancreas: A Joint Statement Endorsed by EPC, APA, EASD, EASL, ESGAR, ESGE, ESP, ESPCG, ESPEN, ESPGHAN, IAP, JPS, KPBA, LAPSG, and UEGMiroslav Vujasinovic, Ihsan Ekin Demir, Giovanni Marchegiani, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Biochemical Pharmacology|March 16, 2025
Loss of aryl hydrocarbon receptor reduces pancreatic tumor growth by increasing immune cell infiltrationVinicius Kannen, Ninni E Olafsen, Siddhartha Das, et al.
Frontiers in Immunology|January 27, 2025
Loss of <i>Parp7</i> increases type I interferon signalling and reduces pancreatic tumour growth by enhancing immune cell infiltrationVinicius Kannen, Marit Rasmussen, Siddhartha Das, et al.
Scandinavian Journal of Gastroenterology|February 14, 2026
A decade of collaborative research: insights from the Scandinavian Baltic Pancreatic Club database on chronic pancreatitisMiroslav Vujasinovic, Mikael Parhiala, Søren S Olesen, et al.
The American Journal of Gastroenterology|February 12, 2019
Chronic Pancreatitis Is Characterized by Distinct Complication Clusters That Associate With Etiological Risk FactorsSøren S Olesen, Camilla Nøjgaard, Jakob L Poulsen, et al.
Scandinavian Journal of Gastroenterology|May 5, 2017
The Scandinavian baltic pancreatic club (SBPC) database: design, rationale and characterisation of the study cohortSøren S Olesen, Jakob L Poulsen, Asbjørn M Drewes, et al.
United European Gastroenterology Journal|February 14, 2026
International Multidisciplinary Consensus Report on Definitions, Diagnostic Criteria, and Management of Fatty Pancreas: A Joint Statement Endorsed by EPC, APA, EASD, EASL, ESGAR, ESGE, ESP, ESPCG, ESPEN, ESPGHAN, IAP, JPS, KPBA, LAPSG, and UEGMiroslav Vujasinovic, Ihsan Ekin Demir, Giovanni Marchegiani, et al.
Pageof 8